Pharmacokinetics and residues of florfenicol in Nile tilapia (Oreochromis niloticus) post-oral gavage

• Published in: Environmental toxicology and pharmacology Vol. 108; p. 104471
• Main Authors: Bardhan, Avishek, Abraham, Thangapalam Jawahar, Sar, Tapas Kumar, Rajisha, Ravindran, Panda, Satyen Kumar, Patil, Prasanna Kumar
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.06.2024
• Subjects: Antibiotic; Aquaculture; Florfenicol amine; Minimal inhibitory concentration; Nile tilapia; Florfenicol amine; Minimal inhibitory concentration; Antibiotic; Nile tilapia; Aquaculture
• ISSN: 1382-6689; 1872-7077
• DOI: 10.1016/j.etap.2024.104471

In the study on Oreochromis niloticus, singular oral gavage of florfenicol (FFC) at 15 mg/kg biomass/day was conducted, mimicking approved aquaculture dosing. Samples of plasma, bile, muscle, intestine, skin, liver, kidney, gill, and brain tissues were collected at 0, 2, 3, 4, 6, 8, 12, 16, 24, 32, 48, 64, 96, and 128 hours (h) after oral gavage. LC-MS/MS analysis revealed FFC concentrations peaked at 12.15 μg/mL in plasma and 77.92 μg/mL in bile, both at 24 hours. Elimination half-lives were 28.17 h (plasma) and 26.88 h (bile). The residues of FFC ranked muscle>intestine>skin>liver>kidney>gill. In contrast, the residues of florfenicol amine (FFA) ranked kidney>skin>liver>muscle>gill>intestine>brain, particularly notable in tropical summer conditions. The minimum inhibitory concentration of FFC was elucidated against several bacterial pathogens revealing its superior efficacy. Results highlight bile's crucial role in FFC elimination. Further investigation, especially during winter when fish susceptibility to infections rises, is warranted. [Display omitted] •Low FFC MIC and MBC against tested strains elucidated superior therapeutic efficacy.•Low absorption half-life in plasma compared to bile.•Biliary excretion pathway of FFC is a significant viable pathway in O. niloticus.